XWELL (NASDAQ:XWEL) Downgraded by Wall Street Zen to Sell

Wall Street Zen lowered shares of XWELL (NASDAQ:XWEL) from a hold rating to a sell rating in a research report released on Sunday.

Separately, Weiss Ratings downgraded shares of XWELL from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has a consensus rating of “Sell”.

XWELL Price Performance

Shares of XWELL stock opened at $1.47 on Friday. The company has a market cap of $11.66 million, a price-to-earnings ratio of -0.29 and a beta of 1.01. The company’s 50 day moving average is $1.28 and its 200 day moving average is $0.87. XWELL has a twelve month low of $0.26 and a twelve month high of $2.20.

XWELL (NASDAQ:XWEL) last issued its quarterly earnings data on Wednesday, April 1st. The company reported ($3.29) earnings per share for the quarter. The company had revenue of $7.15 million for the quarter. XWELL had a negative net margin of 58.17% and a negative return on equity of 352.37%.

XWELL Company Profile

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.